Tempus: Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a...

The latest from the Proscia blog In a recent Today’s Clinical Lab webinar, our Chief Strategy Officer Nathan Buchbinder led a discussion on insights stemming from The 2025 Laboratory Leadership Report. He was joined by three of our...

Roche: Information platform empowers the public with knowledge on latest cancer treatment technologies According to data from the Hong Kong Cancer Registry of the Hospital Authority, the overall five-year survival rate for cancer patients has...

Proscia: Survey of 360 senior professionals finds modernization is key to overcoming longstanding industry challenges PHILADELPHIA — June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI)...

Recognition underscores the impact of Proscia in advancing precision medicine from drug discovery to diagnostics PHILADELPHIA — June 3, 2025 — Proscia®, a software company accelerating pathology’s transition to digital and AI, today...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced diagnostic tools aimed at expanding precision medicine. Leveraging DHR’s newly...